Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Way ANOVA: Equal Sample Sizes01:15

One-Way ANOVA: Equal Sample Sizes

3.5K
One-Way ANOVA can be performed on three or more samples with equal or unequal sample sizes. When one-way ANOVA is performed on two datasets with samples of equal sizes, it can be easily observed that the computed F statistic is highly sensitive to the sample mean.
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
3.5K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

844
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
844
Statistical Significance01:50

Statistical Significance

20.6K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
20.6K
Testing a Claim about Mean: Known Population SD01:11

Testing a Claim about Mean: Known Population SD

2.9K
A complete procedure of testing the hypothesis about a population mean is explained here.
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
2.9K
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

14.8K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
14.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

207
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Golgi casein kinase-mediated phosphorylation of osteopontin orchestrates macrophage- lung-resident mesenchymal stem cells crosstalk and fibrogenesis: a targetable macromolecular axis.

International journal of biological macromolecules·2026
Same author

Ultrafast Hopping Transfer Enables High-Anion Conduction.

Journal of the American Chemical Society·2026
Same author

AL109933.1 inhibits hepatocellular carcinoma progression via downregulating the Warburg effect and inactivating the YY1/PKM2/PIK3R1/PI3K/AKT/ mTOR/HIF-1α axis.

Cellular signalling·2026
Same author

How should covariates be handled in randomized trials? Empirical evidence from 50 trials and recommendations for practice.

Journal of clinical epidemiology·2026
Same author

A quantitative framework to assess the potential of earlier cancer detection to improve cancer survival.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Histotripsy dose impacts tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinoma.

Scientific reports·2026
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Oct 24, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K

A generalizability score for aggregate causal effect.

Rui Chen1, Guanhua Chen2, Menggang Yu2

  • 1Department of Statistics, University of Wisconsin, Madison, WI, 53715, USA.

Biostatistics (Oxford, England)
|August 12, 2021
PubMed
Summary
This summary is machine-generated.

Generalizing causal effects between populations is challenging due to differing characteristics. A new generalizability score helps select appropriate target subpopulations, improving reliability and avoiding bias.

Keywords:
Average treatment effectGeneralizabilityPropensity scoreTreatment effect heterogeneity

More Related Videos

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

4.1K
Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
14:06

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays

Published on: November 12, 2012

46.6K

Related Experiment Videos

Last Updated: Oct 24, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K
Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

4.1K
Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays
14:06

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays

Published on: November 12, 2012

46.6K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Causal Inference

Background:

  • Generalizing population-level causal quantities (e.g., average treatment effect) across different populations is common in scientific research.
  • Heterogeneity in causal effects and differences in subject characteristics between source and target populations can hinder reliable generalization.
  • Existing methods like reweighting or regression may suffer from high variance when covariate distribution overlap is limited.

Purpose of the Study:

  • To propose a novel generalizability score to address challenges in causal effect generalization.
  • To provide a metric for selecting suitable target subpopulations for reliable generalization.
  • To develop a simplified score variant that mitigates bias by excluding outcome information.

Main Methods:

  • Development of a generalizability score to quantify the suitability of target subpopulations.
  • Introduction of a simplified score version that does not require outcome data, preventing potential biases.
  • Validation through simulation studies and real-world data analysis.

Main Results:

  • The proposed generalizability score effectively serves as a yardstick for selecting target subpopulations.
  • The simplified score variant successfully avoids biases associated with outcome information.
  • Both simulation and real data analyses confirmed the score's utility and convincing results.

Conclusions:

  • The generalizability score offers a robust method for improving the reliability of causal effect generalization.
  • The score facilitates informed selection of target subpopulations, particularly in cases of limited covariate overlap.
  • The outcome-independent version enhances the score's applicability and reduces the risk of deliberate or inadvertent bias.